lesions may be resistant to treatment and pre-destined for cancer development, although this seems a distinctly negative perspective. 9 We have previously documented clinical outcomes in a 590 PMD patient cohort undergoing standardised interventional CO 2 laser treatment, primarily excision surgery but also utilising ablation techniques for small or less dysplastic lesions on gingival and alveolar sites. 6 Post-treatment, 404 patients from this cohort (68.4%) were found to be disease free, 99 (16.8%) exhibited unexpected or subsequently developing SCC, whilst 87 were resistant to treatment developing further or persistent PMD disease during the mean 7.3 years follow-up period. 4, 5 The specific purpose of this study therefore was to review in depth the clinico-pathological features of these 87 'treatment resistant' PMDs, to document each individual patient 'journey' and try to improve knowledge of the natural history of PMD disease and thereby identify features potentially predictive of poor outcome post-treatment. All biopsies and CO 2 laser surgeries were carried out by the first author (PJT), or colleagues working under direct supervision, to established guidelines and within 6-12 weeks of initial presentation to prevent disease progression. 4 Formalin-fixed tissue specimens
| ME TH OD
were assessed via standardised histopathology examination by oral pathologists at the Royal Victoria Infirmary using agreed diagnostic criteria, peer review and consensus grading. 4 The World Health T A B L E 1 Clinico-pathological, treatment and clinical outcome details for disease-free patients (N = Table 3 summarises statistical comparisons between disease-free and persistent patient groups. No significant differences were seen for patient age and sex, nor for individual PMD lesion clinical appearance, site or histopathology diagnoses, including PVL or LI recognition. Statistical significance was identified, however, for a change in PMD appearance between initial and subsequent lesions (P = .004) and for treatment intervention, both in terms of multiple versus single treatment (P = .0005) and the use of excision rather than ablation techniques (P = .027).
| Persistent disease patients

| Statistical comparison
| DISCUSSION
The efficacy of interventional laser surgery, as both a diagnostic and treatment tool, has been well documented. 10 Recognition that 70%
of 'high-risk' PMD patients can achieve disease-free status by intervention is unquestionably a treatment success. 4, 8 It is, however, the Disease-free patients were slightly younger, often had lesions that changed appearance from erythroleukoplakia to 'lower risk' leukoplakia, developed further PMDs at new sites and, whilst often exhibiting quite severe dysplasia in presenting lesions, generally showed a reduction in severity in subsequent lesions.
In contrast, the persistent disease cohort were generally older, more often male, frequently exhibited leukoplakia with PVL features at gingival and alveolar sites, and displayed less severe dysplasia in initial biopsies. Clinical appearance of lesions was more consistent between initial and further presentation, and same-site disease more prevalent.
Diagnoses of PVL, with or without dysplasia, were made more frequently during later years of the study (2007 onwards), probably due to enhanced awareness amongst pathologists of the risks for persistent PMD disease and increased malignant transformation in PVL. 11 Although the identification of LI within PMD lesions has been linked to persistent and unfavourable disease outcome, 12 no significant influence was seen on treatment resistance in this investigation.
| The patient 'Journey'
Active patient surveillance post-intervention is advised, not only to review treatment efficacy but also to effectively monitor patients for further disease, to recognise early signs of malignancy and to improve understanding of PMD natural history. 8, 13 Despite consistent management decisions and repeated treatment, the 53 patient 'journeys' summarised in Table 2 led to persistent disease outcomes.
| Treatment intervention
Whilst all PMD treatments were coordinated by the first author (PJT) and proceeded along well-established and consistent management guidelines, 4, 8, 10, 14 it is clear that fewer interventions per patient were performed in the persistent disease group. Although many of these treatments comprised laser ablation of gingival and alveolar PVL, as previously advocated for this type of presentation, 8, 14 repeat excision surgeries for more significant dysplastic lesions were also carried out, obviously with reduced efficacy compared to disease-free cases.
Whilst it is likely that individual management decisions and It is, however, notable that repeat excision surgeries were performed much more frequently in patients achieving disease-free status than those with persistent disease. Is the answer to PMD 
